Most medications are considered for people with a BMI of 30 or higher, or a BMI of 27 with conditions such as high blood pressure, type 2 diabetes, or sleep apnea
Maciel-Baron, L
Shifts on gut microbiota associated to mediterranean diet adherence and specific dietary intakes on general adult population
Enter Bimagrumab: A Muscle-Sparing Antibody Bimagrumab represents a new category of therapy
Glutamate-receptor-like molecule GluRdelta2 involved in synapse formation at parallel fiber-Purkinje neuron synapses
Medicina (Kaunas) 58(10):1382 Yang A, Wu H, Lau ESH, Zhang X, Shi M, Fan B, et al (2022) Glucose-lowering drug use, glycemic outcomes, and severe hypoglycemia: 18-year trends in 09 million adults with diabetes in Hong Kong (20022019)